Understanding Rotavirus and Its Vaccines
Author Information
Author(s): Umesh D. Parashar, Joseph S. Bresee, Jon R. Gentsch, Roger I. Glass
Primary Institution: Centers for Disease Control and Prevention
Hypothesis
Rotavirus diarrhea might be controlled through vaccination.
Conclusion
The tetravalent rhesus-human reassortant rotavirus vaccine (RRV-TV) provides significant protection against rotavirus diarrhea in children.
Supporting Evidence
- Rotavirus is the most common cause of severe diarrhea in children worldwide.
- RRV-TV showed 49% to 68% protection against any rotavirus diarrhea.
- RRV-TV was licensed by the U.S. Food and Drug Administration on August 31, 1998.
- The vaccine's efficacy in developing countries needs further evaluation.
Takeaway
Rotavirus is a virus that makes kids sick with diarrhea, but a new vaccine can help protect them from getting sick.
Methodology
The study involved clinical trials of the RRV-TV vaccine in infants, assessing its safety and efficacy.
Potential Biases
Potential bias in efficacy results due to varying conditions in different countries.
Limitations
The efficacy of the vaccine in developing countries may vary due to factors like nutritional status and presence of other pathogens.
Participant Demographics
Infants aged 2 to 18 months from various countries.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website